Vaccine and Infectious Disease Organization–International Vaccine Centre (VIDO-InterVac)

Vaccine and Infectious Disease Organization–International Vaccine Centre (VIDO-InterVac)
Name	Vaccine and Infectious Disease Organization–International Vaccine Centre
Established	1975
Location	Saskatoon, Saskatchewan, Canada

Vaccine and Infectious Disease Organization–International Vaccine Centre (VIDO-InterVac) is a Canadian research institute based in Saskatoon, Saskatchewan focused on vaccine development, infectious disease research, and biocontainment laboratory infrastructure. The centre integrates preclinical testing, antigen discovery, and translational research to support responses to zoonotic and human pathogens, working with international partners in public health, agriculture, and academia. VIDO-InterVac operates within a network of provincial, national, and global institutions to accelerate vaccine candidates from concept to regulatory submission.

History

VIDO-InterVac traces origins to research programs at the University of Saskatchewan established in the 1970s, evolving through provincial support and federal initiatives to address emerging threats such as bovine spongiform encephalopathy, avian influenza, and COVID-19 pandemic. Institutional milestones include expansion of laboratory capacity following collaborations with the Canadian Institutes of Health Research, construction of high-containment facilities modeled on standards set by the Canadian Food Inspection Agency and influence from global biosafety frameworks promulgated after incidents like the 2003 SARS outbreak. The centre’s growth paralleled investments in Canadian biotechnology policy linked to agencies such as Genome Canada and partnerships with industrial actors including multinational vaccinology firms.

Mission and Mandate

VIDO-InterVac’s mandate emphasizes translational vaccine research for priority pathogens affecting public health and animal health with an emphasis on zoonoses, emerging infections, and antimicrobial-resistant organisms. The mission aligns with international guidance from bodies such as the World Health Organization, the Food and Agriculture Organization, and the World Organisation for Animal Health to promote One Health approaches. Its stated goals include accelerating candidate vaccines to licensure, providing preclinical services for regulatory dossiers submitted to agencies like Health Canada and international regulatory authorities, and supporting capacity building in low- and middle-income countries through technology transfer and training.

Facilities and Biosafety Laboratories

VIDO-InterVac houses multiple biosafety containment suites, including facilities meeting Biosafety Level 3 standards for work on airborne pathogens and select agent research. The complex was designed to provide animal biosafety containment for species ranging from livestock to laboratory rodents, integrating veterinary isolation suites and controlled-access infrastructure. Its laboratory design was influenced by international standards developed by organizations such as the Public Health Agency of Canada and the Centers for Disease Control and Prevention. The facility’s biocontainment enables challenge studies, immunogenicity testing, and efficacy trials that require compliance with standards endorsed by the Canadian Council on Animal Care and interacts with clinical trial networks such as those coordinated by Canadian Institutes of Health Research.

Research Programs and Vaccines

VIDO-InterVac conducts translational projects across viral, bacterial, and parasitic targets, contributing to vaccine pipelines for pathogens including influenza virus, coronavirus, respiratory syncytial virus, and livestock pathogens like Mycoplasma bovis and bovine viral diarrhea virus. Research themes encompass antigen discovery, adjuvant evaluation, delivery platforms, and correlates of protection, employing model systems used by groups at institutions such as the National Institutes of Health, Imperial College London, and Johns Hopkins University. During the COVID-19 pandemic, the centre advanced candidate vaccines and collaborated on neutralization assays, challenge models, and preclinical safety studies analogous to work by the Oxford Vaccine Group and industrial developers like Moderna and Pfizer.

Partnerships and Collaborations

VIDO-InterVac maintains partnerships with universities, government agencies, international organizations, and industry. Key collaborators have included the University of Saskatchewan, provincial ministries, the Public Health Agency of Canada, multilateral entities such as the Coalition for Epidemic Preparedness Innovations, and private-sector partners across biotechnology and pharmaceutical sectors. International collaborations extend to institutions in Africa, Asia, and Latin America for capacity building and field trials, mirroring cooperative efforts seen in networks coordinated by Gavi, the Vaccine Alliance and PATH.

Training, Outreach, and Technology Transfer

The centre provides training programs for scientists, veterinarians, and technical staff in high-containment laboratory techniques, animal challenge studies, and regulatory science, partnering with academic departments at the University of Saskatchewan and professional bodies such as the Canadian Veterinary Medical Association. Outreach activities include stakeholder engagement with agricultural producers, public health agencies, and indigenous communities, and technology transfer initiatives supporting commercialization alongside organizations like Innovation Saskatchewan and provincial economic development agencies. VIDO-InterVac has hosted delegations from multilateral donors and participated in WHO-coordinated trainings and proficiency testing schemes.

Funding and Governance

VIDO-InterVac’s funding model combines provincial appropriations, competitive grants from agencies including the Canadian Institutes of Health Research and Natural Sciences and Engineering Research Council, philanthropy, and contracts with industry and international donors. Governance involves oversight by a board of directors and alignment with university research policies at the University of Saskatchewan, with accountability mechanisms consistent with funding agreements from entities such as Genome Canada and provincial ministries. Strategic priorities are influenced by national biosecurity directives, international health commitments, and stakeholder input from research consortia and commercialization partners.

Category:Research institutes in Canada Category:Vaccinology